Dupont Capital Management Corp Adma Biologics, Inc. Transaction History

Dupont Capital Management Corp

  • $1.18 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 29, 2020
SELL
$2.04 - $3.74 $152,049 - $278,757
-74,534 Closed
0 $0
Q2 2020

Jul 24, 2020
SELL
$2.42 - $3.29 $3,392 - $4,612
-1,402 Reduced 1.85%
74,534 $218,000
Q1 2020

Apr 29, 2020
BUY
$1.5 - $4.59 $113,904 - $348,546
75,936 New
75,936 $219,000

Others Institutions Holding ADMA

# of Institutions
318
Shares Held
184M
Call Options Held
917K
Put Options Held
91.6K
View Full List

About ADMA BIOLOGICS, INC.

ADMA Quotes by TradingView
  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.64B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email